Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer

Deregulated expression of the MET receptor tyrosine kinase has been reported in up to 50% of patients with hepatocellular carcinoma, the most abundant form of liver cancers, and is associated with decreased survival. Consequently, MET is considered as a molecular target in this malignancy, whose pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Piguet, Anne-Christine, Medová, Michaela, Keogh, Adrian, Glück, Astrid A., Aebersold, Daniel M., Dufour, Jean-François, Zimmer, Yitzhak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575919/
https://www.ncbi.nlm.nih.gov/pubmed/26413215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575919/
https://www.ncbi.nlm.nih.gov/pubmed/26413215

Ejemplares similares